World CNS Summit Boston, Massachusetts, USA 20-22 February 2018

Description:
The last 12 months have seen the neurodegenerative community make numerous strides into understanding these disorders. However, 2017 has been a rocky journey, particularly so for Alzheimer’s Disease, adding weight to the growing concern as to whether there is a fundamental flaw in our understanding of the disease, its mechanisms or our path to targeting it.

As Program Director & Researcher for the 6th Annual World CNS Summit, I invite you to join a truly diverse group of professionals from biopharmaceutical, technology and academic institutions, in paving the path forward for neurodegenerative therapeutics.

Brochure: https://go.evvnt.com/171844-1
Booking: https://go.evvnt.com/171844-2

Price
Conference Only - Standard Industry Pricing: USD 2799
Workshop Only - Standard Industry Pricing: USD 699
Conf + 1 Workshop - Standard Industry Pricing: USD 3398
Conf + 2 Workshops: USD 3997
Conf + 3 Workshops: USD 4596

Speakers: Tarek Samad (Pfizer), Holly Soares (AbbVie), Richard Ransohoff (Biogen), Alice Zhang (Verge Genomics), Martin Tolar (Alzheon Inc), S Pablo Sardi (Sanofi-Genzyme), Johan Luthman (Eisai Pharmaceuticals), Susan Browne (Teva Pharmaceuticals), Damian Crowther (AstraZeneca)

Time: on Tuesday February 20, 2018 at 8:00 am (ends Thursday February 22, 2018 at 5:00 pm)